患者参与管理模式在2型糖尿

发布时间：2018-11-10 12:15

【摘要】：目的验证患者参与管理模式对接受"3C"治疗的T2DM患者血糖控制效果。方法选取泰达国际心血管病医院内分泌科住院的T2DM并接受"3C"治疗的患者125例,随机分为患者参与管理模式组65例和常规模式组60例。结果出院时,患者参与管理模式组FPG[(7.69±1.05)vs(7.13±1.13)mmol/L]、2 hPG[(9.85±1.29)vs(9.10±1.11)mmol/L]、日间血糖平均绝对差(MODD)[(1.90±0.35)vs(1.44±0.25)]、平均血糖波动幅度(MAGE)[(1.36±0.27)vs(1.21±0.21)]与常规模式组比较,差异均有统计学意义(P0.05)。出院3个月后门诊随访,两组Vm[(8.14±1.25)vs(7.59±1.33)mmol/L]、2 hPG[(10.55±1.49)vs(9.79±1.51)mmol/L]、HbA_1c[(7.74±0.67)%vs(7.42±0.89)%]比较,差异均有统计学意义(P0.05)。出院6个月后门诊随访,两组FPG[(8.20±1.36)vs(7.79±1.32)mmol/L]、2 hPG[(10.98±1.69)vs(9.95±1.61)mmol/L]和HbA_1c[(7.84±1.02)%vs(7.40±0.95)%]比较,差异仍有统计学意义(P0.05)。结论患者参与管理模式不仅可在住院期间提高"3C"治疗对血糖控制的效果,且在院外也能改善患者血糖状况。
[Abstract]:Objective to verify the effect of patient participation management model on blood glucose control in T2DM patients receiving 3C therapy. Methods 125 patients with T2DM in Endocrinology Department of Teda International Cardiovascular Disease Hospital were randomly divided into two groups: 65 patients in the management model group and 60 patients in the routine mode group. Results at discharge, FPG [(7.69 卤1.05) vs (7.13 卤1.13) mmol/L], 2 hPG [(9.85 卤1.29) vs (9.10 卤1.11) mmol/L] were involved in the management model group. The mean absolute difference (MODD) of blood glucose between days [(1.90 卤0.35) vs (, 1.44 卤0.25)], and the mean fluctuation amplitude of blood glucose (MAGE) [(1.36 卤0.27) vs (, 1.21 卤0.21)] were compared with those of the normal model group. The difference was statistically significant (P0.05). Three months after discharge, Vm [(8.14 卤1.25) vs (7.59 卤1.33) mmol/L], 2 hPG [(10.55 卤1.49) vs (9.79 卤1.51) mmol/L] were followed up. The difference of HbA_1c [(7.74 卤0.67)% vs (7.42 卤0.89)%] was statistically significant (P0.05). Six months after discharge, the FPG of the two groups was followed up [(8.20 卤1.36) vs (7.79 卤1.32) mmol/L]. 2 the differences of hPG [(10.98 卤1.69) vs (9.95 卤1.61) mmol/L] and HbA_1c [(7.84 卤1.02)% vs (7.40 卤0.95)%] were still statistically significant (P0.05). Conclusion the model of patient participation management can not only improve the effect of "3C" treatment on blood glucose control during hospitalization, but also improve the blood sugar status of patients outside hospital.
【作者单位】：天津医科大学公共卫生学院;泰达国际心血管病医院内分泌科;泰达国际心血管病医院护理部;
【分类号】：R587.1

【相似文献】